Clinical Trial Update: JAK Inhibitors' Efficacy in Bullous Pemphigoid

View source ↗

Summary

A completed clinical trial evaluating the efficacy of Janus kinase inhibitors in treating bullous pemphigoid has been updated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Pemphigoid

Snippet

Sponsor: Chao Ji | Conditions: Bullous Pemphigoid, Janus Kinase Inhibitor | Status: COMPLETED